Zhejiang Hisoar Pharmaceutical Co., Ltd. (SHE:002099)
China flag China · Delayed Price · Currency is CNY
5.47
+0.25 (4.79%)
Jul 29, 2026, 3:04 PM CST

Zhejiang Hisoar Pharmaceutical Company Description

Zhejiang Hisoar Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates in China and internationally.

It operates through Pharmaceutical Industry, Dye Industry, and Others segments. The company offers antibiotics, cardiovascular drugs, hypoglycemic agents, formulations, and fine chemicals.

It also provides dyes and pigment intermediates; environmental protection-related equipment; medical chemical supplies and appliances; and other chemical intermediates.

In addition, the company engages in technology research and development; trading; hazardous waste treatment; equity investment; technical consulting and other consulting services; and venture capital activities.

It exports its products to approximately 30 countries, including Europe, America, and Asia. Zhejiang Hisoar Pharmaceutical Co., Ltd. was founded in 1966 and is headquartered in Taizhou, China.

Zhejiang Hisoar Pharmaceutical Co., Ltd.
CountryChina
Founded1966
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees2,736
CEOGuorui Xu

Contact Details

Address:
No. 100, Waisha Branch Road
Taizhou, 318000
China
Phone86 576 8908 8829
Websitehisoar.com

Stock Details

Ticker Symbol002099
ExchangeShenzhen Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyCNY
ISIN NumberCNE000001PY2
SIC Code2833

Key Executives

NamePosition
Guorui XuGM and Director
Bing YaoVice President, Chief Financial Officer, Board Secretary and Director
Wen Hua MaoDeputy General Manager
Haiyan ZhouAccounting Supervisor
Qing Hua PanVice President
Guangshun ChenVice President and Non Independent Director